YO

Yutaka Ogihara

Representative Director, President & CEO

KYORIN Pharmaceutical

KYORIN Pharmaceutical Pipeline

DrugIndicationPhase
Refuna (Gefapixant)Refractory/Unexplained Chronic CoughMarketed
BDT272Neuropathic PainPreclinical
Satiro TabletsTuberculosisRegistration
Beova (Imidafenacin)Overactive BladderMarketed
Eclira Genuair (Acidinium Bromide)COPDMarketed
FlutiformAsthmaMarketed
Lasvic (Lascufloxacin)Bacterial InfectionsMarketed
Jimso Bladder InstillationInterstitial CystitisMarketed